December 03, 2024FinancialNotice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
December 03, 2024CorporateMulti-Center Superiority Clinical Trial, Supported by Terumo Blood and Cell Technologies, Aims to Significantly Reduce Complications From Acute Chest Syndrome in Adult Sickle Cell Disease Patients
December 03, 2024CorporateTerumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support CatheterProvides interventionalists with optimal product choices for more complex radial-to-peripheral procedures
Terumo Corporation ME Center 1002-1 Shimonagakubo, Nagaizumi-cho Suntou-gun, Shizuoka, 411-0934, Japan
Top
Top